NCT06395662View on ClinicalTrials.gov

Stratification of Risks of Conversion of Radiologically Isolated Syndromes (RIS) by Identifying Biomarkers in Serum and Cerebrospinal Fluid.

Active, not recruitingOBSERVATIONAL
Enrollment

320

Participants

Timeline

Start Date

April 15, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

July 31, 2025

Conditions
Radiologically Isolated SyndromeMultiple Sclerosis
Interventions
OTHER

Observational

Search for biomarkers

Trial Locations (3)

69364

INTERNATIONAL CENTER OF RESEARCH IN INFECTIOLOGY, LYON UNIVERSITY, INSERM U1111, CNRS UMR 5308, ENS, UCBL 46 Allée d'Italie, Lyon

75390

University of Texas, Southwestern, Dallas

06001

COTE D'AZUR UNIVERSITY, URRIS-UR2CA. Hôpital Pasteur 2, 30, Voie Romaine, Nice

All Listed Sponsors
collaborator

International Center of Research in Infectiology, Lyon University

UNKNOWN

collaborator

Universite Cote d'Azur

OTHER

collaborator

The University of Texas at Dallas

OTHER

lead

Centre Hospitalier Universitaire de Nīmes

OTHER

NCT06395662 - Stratification of Risks of Conversion of Radiologically Isolated Syndromes (RIS) by Identifying Biomarkers in Serum and Cerebrospinal Fluid. | Biotech Hunter | Biotech Hunter